Physician profile
Robert E Berg
NPI 1336105436
$5,200.11
in general payments reported to CMS, 2019-2025
37 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,112 · 2020: $465 · 2021: $1,061 · 2022: $1,134 · 2023: $656 · 2024: $547 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,428.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,132.23 | 2019-2024 | Qulipta, Lo Loestrin Fe, Orilissa |
| Sumitomo Pharma America, INC. | $482.43 | 2023-2025 | Myfembree, Gemtesa |
| Baxter Healthcare | $474.41 | 2019-2024 | Perclot, Tisseel |
| Myovant Sciences INC. | $417.66 | 2021-2022 | |
| Daiichi Sankyo INC. | $247.61 | 2020-2023 | Injectafer |
| Hologic Sales and Service, LLC | $220.48 | 2019-2025 | Myosure Tissue Removal Device, Acessa Provu System |
| Aspira Women'S Health INC | $205.94 | 2021 | |
| Amag Pharmaceuticals, INC. | $163.96 | 2019 | |
| Avion Pharmaceuticals | $161.33 | 2019-2022 | |
| Astellas Pharma US INC | $150.49 | 2023-2025 | Veozah |
| Mimedx Group, INC. | $141.39 | 2024 | |
| Lupin INC. | $140.27 | 2019-2020 | |
| Gynesonics, INC. | $131.51 | 2021 | |
| Merck Sharp & Dohme LLC | $105.36 | 2019-2021 | |
| Evofem Biosciences, INC. | $103.07 | 2021-2023 | Phexxi |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $100.11 | 2020-2025 | Slynd |
| Momentis Surgical INC. | $98.00 | 2022 | |
| Allergan, INC. | $86.13 | 2019 | |
| Mayne Pharma Commercial LLC | $78.28 | 2022-2023 | |
| Amgen INC. | $77.72 | 2019 | |
| Intuitive Surgical, INC. | $65.61 | 2023 | Da Vinci Surgical System |
| Duchesnay USA Incorporated | $46.96 | 2019 | |
| Argenx US, INC. | $41.35 | 2023 | Vyvgart |
| Bayer Healthcare Pharmaceuticals INC. | $38.16 | 2019-2021 | |
| Mission Pharmacal Company | $37.92 | 2019 | |
| Renovia INC | $29.73 | 2019 | |
| Agile Therapeutics, INC. | $27.36 | 2021 | |
| Coopersurgical, INC. | $25.01 | 2020 | |
| Biogen, INC. | $24.17 | 2025 | Zurzuvae |
| Pfizer INC. | $22.28 | 2024 | |
| Lilly USA, LLC | $21.47 | 2019 | |
| Vertical Pharmaceuticals, LLC | $19.91 | 2019 | |
| Mylan Pharmaceuticals INC. | $19.12 | 2019 | |
| Organon LLC | $17.45 | 2024 | |
| Boston Scientific Corporation | $16.63 | 2019 | |
| Millicent US INC | $14.90 | 2019 | |
| Channel Medsystems, INC. | $13.70 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Berg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.